ASX:AC8 AusCann Group (AC8) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About AusCann Group Stock (ASX:AC8) 30 days 90 days 365 days Advanced Chart Get AusCann Group alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume537,446 shsAverage VolumeN/AMarket CapitalizationA$17.62 millionP/E RatioN/ADividend Yield6.79%Price TargetN/AConsensus RatingN/A Company Overview AusCann Group Holdings Ltd engages in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. Its principal product includes the novel tetrahydrocannabinol and cannabidiol (THC/CBD), a powder-based hard-shell capsules based on AusCann's Neuvis platform for the treatment of pain and related indications. The company is also involved in the research and development of medicinal cannabis. It offers its products to healthcare professionals and veterinarians. AusCann Group Holdings Ltd is based in West Perth, Australia. Read More Receive AC8 Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AusCann Group and its competitors with MarketBeat's FREE daily newsletter. Email Address AC8 Stock News HeadlinesAusCann Group Holdings Ltd (ACNNF)August 23, 2024 | finance.yahoo.comPro Tips For Using The AC-8 Autocannon In Helldivers 2April 28, 2024 | msn.comI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong. | Porter & Company (Ad)AusCann Group Holdings Stock (OTC:ACNNF) Dividends: History, Yield and DatesJanuary 1, 2024 | benzinga.comAC8.AX - AusCann Group Holdings LtdJune 2, 2023 | finance.yahoo.comAussie pot stock update: Here’s what you missed this monthMay 5, 2023 | fool.com.auHere are 3 recent IPOs every investor should know aboutApril 26, 2023 | fool.com.auACNNF AusCann Group Holdings LtdMarch 28, 2023 | seekingalpha.comSee More Headlines AC8 Stock Analysis - Frequently Asked Questions What other stocks do shareholders of AusCann Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that AusCann Group investors own include 3D Systems (DDD), Bristol Myers Squibb (BMY), Johnson & Johnson (JNJ), Workday (WDAY), Zoom Communications (ZM), Zynerba Pharmaceuticals (ZYNE) and Ambarella (AMBA). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:AC8 CIKN/A Webwww.auscann.com.au Phone61 0 9561 8834FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$9.44 million Net MarginsN/A Pretax MarginN/A Return on Equity-1.09% Return on Assets-1.67% Debt Debt-to-Equity RatioN/A Current Ratio33.22 Quick Ratio20.17 Sales & Book Value Annual SalesA$1.36 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.05 Book ValueA$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares440,550,000Free FloatN/AMarket CapA$17.62 million OptionableNot Optionable Beta0.72 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (ASX:AC8) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AusCann Group Holdings Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share AusCann Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
